Total amount raised
$42.8 Millions
Latest funding date
08/01/2022
Location
January AI has successfully raised multiple funding rounds, with the latest being a "Venture - Series Unknown" round that closed on August 15, 2022. The company is backed by 10 investors, including notable names like Marissa Mayer and Mostafa Ronaghi.
January AI offers personalized nutrition coaching to help users optimize their metabolism and achieve health goals such as weight loss and blood sugar management. Keep reading to explore the intricacies of January AI's fundraising journey and the investors backing this innovative platform.
What Is January AI?
January AI, founded on April 1, 2017, is a precision health company based in Menlo Park, California. The company was established by Noosheen Hashemi and Dr. Michael Snyder.
Operating within the health and wellness technology industry, January AI leverages artificial intelligence to offer personalized nutrition coaching. The company employs continuous glucose monitoring, heart rate, sleep, activity, and food tracking to provide real-time insights into metabolic health.
With a team of 11-50 employees, January AI aims to help users understand their body's metabolism and make lifestyle changes to improve overall health and prevent serious conditions like pre-diabetes.
How Much Funding Has January AI Raised?
- Seed Round
- Amount Raised: $1.5M
- Date: May 2017
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To kickstart the company's operations and initial product development.
- Seed Round
- Amount Raised: $19.5M
- Date: June 2019
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand the company's research and development efforts and enhance its AI capabilities.
- Venture Round
- Amount Raised: $8.8M
- Date: February 2021
- Lead Investors: Felicis Ventures, HAND Capital, Marc Benioff
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand operations, hire key personnel, and accelerate sign-ups for the company's health program.
- Venture Round
- Amount Raised: $13M
- Date: August 2022
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further scale the company's operations and enhance its product offerings.
Total Amount Raised: $42.8M. Current Valuation: Not publicly disclosed.
Key Investors
- Marissa Mayer
- Details: Former CEO of Yahoo and a well-known tech executive.
- Investment Focus Areas: Technology, AI, innovative startups.
- Notable Investments: Yahoo, Lumi Labs.
- Mostafa Ronaghi
- Details: Co-founder of several biotech companies and a prominent figure in the genomics field.
- Investment Focus Areas: Biotechnology, genomics, health tech.
- Notable Investments: Illumina, Grail.
- Marc Benioff
- Details: CEO of Salesforce, a leading cloud-based software company.
- Investment Focus Areas: Technology, healthcare innovations.
- Notable Investments: Salesforce, Time Magazine.
- Steve Chen
- Details: Co-founder of YouTube, the popular video-sharing platform.
- Investment Focus Areas: Technology startups, digital media.
- Notable Investments: YouTube, AVOS Systems.
- Felicis Ventures
- Details: A venture capital firm founded by Aydin Senkut.
- Investment Focus Areas: Early-stage technology companies.
- Notable Investments: Shopify, Fitbit.
What's Next for January AI?
January AI stands poised to capitalize on the growing focus on metabolic health and personalized medicine. With a substantial market of 122 million Americans affected by diabetes or prediabetes, the company has significant opportunities to expand its "Season of Me" program and collaborate with pharmaceutical companies and employers. The recent $8.8 million funding round will enable January AI to enhance its technology and service offerings, positioning it for further growth.
Future fundraising opportunities appear promising, given the involvement of high-profile investors and the company's innovative approach. However, January AI will need to navigate challenges such as competition from other health tech companies and regulatory hurdles. Ensuring the accuracy and reliability of their predictive algorithms will be crucial as they scale their operations and expand their market reach.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like January AI and gather other critical business insights.
Sign up for free to start exploring the wealth of information available at your fingertips and gain a competitive edge in your sales efforts.
